BTIG Assumes Verastem at Buy, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Justin Zelin has initiated coverage on Verastem (NASDAQ:VSTM) with a Buy rating and set a price target of $27.
November 21, 2023 | 1:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Justin Zelin has assumed coverage on Verastem with a Buy rating and a price target of $27, indicating a positive outlook for the stock.
Analyst ratings, especially with a Buy recommendation, can have a significant positive impact on a stock's price in the short term. The price target of $27 suggests a substantial upside from the current trading price, which could attract investor interest and drive up the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100